Abstract B083: The SC AMEN program: Testing a centralized patient navigation intervention for prostate cancer screening in Black men

Abstract Background: Prostate cancer is the most common type of cancer and the second highest cause of cancer death in the United States (U.S). The prostate cancer incidence and death rates in the U.S. are twice as high among Black men. To address this issue, the Medical University of South Carolina Hollings Cancer Center (MUSC HCC) developed the South Carolina Prostate Cancer Education and Navigation to Screening Program for African American Men (SC AMEN Program). This program includes patient navigators who help to overcome social drivers of health barriers that could prevent Black men from receiving prostate cancer screening. Participants are guided to a physician for an informed decision-making discussion about prostate cancer screening. Methods: The Program includes a one-hour evidence-based prostate cancer educational session. The pre-test survey assesses prostate cancer knowledge using the validated PROCASE scale which is administered again at post-test following the educational session. Each participant is navigated to a physician to discuss prostate cancer screening over the next three months. Results: The 556 participants included Black (98.6%), American Indian/Alaska Native (0.7%), and Native Hawaiian or Other Pacific Islander men (0.4%), with 2.7% reporting Hispanic/Latino ethnicity. The age range of the 556 participants was 40-69 years; 7.6% had less than a high school education, 36.2% completed high school, 18.5% completed some college, and 36.7% were college graduates. The total average (SD) pretest score was 6.7±1.6/10. The total average post-test score was 7.0±1.9/10. The total point increase from pre-test to post-test was 0.3 (p=0.002). Of the 556 SC AMEN Program participants, 77% completed a prostate cancer screening (n=217/39%) or have scheduled a screening appointment (n=209/38%). The remaining 23% continue to be navigated to a screening appointment. Conclusions: The SC AMEN Program was successful in increasing the participants’ knowledge of prostate cancer and their access to prostate cancer screening. Citation Format: Amber S. McCoy, Marvella E. Ford, Angela M. Malek, Melanie Slan, Claudia E. Lawton, Lee H. Moultrie, Kenneth Swaringer, I'Ayana Sanders, Adam Pressley, Ellen Gomez, Jessica zserai, Joan McLauren, pMina Platt, Phuong Le, Chloe Keeve, Joie Zabec, Marla Sagatelian, Benjamin Stone, Nicholas Shungu. The SC AMEN program: Testing a centralized patient navigation intervention for prostate cancer screening in Black men [abstract]. In: Proceedings of the 18th AACR Conference on the Science of Cancer Health Disparities; 2025 Sep 18-21; Baltimore, MD. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2025;34(9 Suppl):Abstract nr B083.

Authors

Institutions

Publication Details

Journal
Cancer Epidemiology Biomarkers & Prevention
Published
2025-09-18
DOI
https://doi.org/10.1158/1538-7755.disp25-b083
Primary Topic
Global Cancer Incidence and Screening
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract B083: The SC AMEN program: Testing a centralized patient navigation intervention for prostate cancer screening in Black men

Chloe Keeve, Ellen Gomez, Lee H. Moultrie, Philip S. Platt et al.
Cancer Epidemiology Biomarkers & Prevention
Global Cancer Incidence and Screening
article

Abstract B083: The SC AMEN program: Testing a centralized patient navigation intervention for prostate cancer screening in Black men

Chloe Keeve, Ellen Gomez, Lee H. Moultrie, Philip S. Platt, Angela M. Malek, Claudia Lawton, Jessica Zserai, Nicholas Shungu, Phuong Mai Le, Benjamin V. Stone, Marvella E. Ford, Melanie Slan, Marla Sagatelian, Joan McLauren, I’Ayana Sanders, Joie Zabec, Aaron McCoy, Adam Pressley, Kenneth Swaringer
article en

Abstract

Abstract Background: Prostate cancer is the most common type of cancer and the second highest cause of cancer death in the United States (U.S). The prostate cancer incidence and death rates in the U.S. are twice as high among Black men. To address this issue, the Medical University of South Carolina Hollings Cancer Center (MUSC HCC) developed the South Carolina Prostate Cancer Education and Navigation to Screening Program for African American Men (SC AMEN Program). This program includes patient navigators who help to overcome social drivers of health barriers that could prevent Black men from receiving prostate cancer screening. Participants are guided to a physician for an informed decision-making discussion about prostate cancer screening. Methods: The Program includes a one-hour evidence-based prostate cancer educational session. The pre-test survey assesses prostate cancer knowledge using the validated PROCASE scale which is administered again at post-test following the educational session. Each participant is navigated to a physician to discuss prostate cancer screening over the next three months. Results: The 556 participants included Black (98.6%), American Indian/Alaska Native (0.7%), and Native Hawaiian or Other Pacific Islander men (0.4%), with 2.7% reporting Hispanic/Latino ethnicity. The age range of the 556 participants was 40-69 years; 7.6% had less than a high school education, 36.2% completed high school, 18.5% completed some college, and 36.7% were college graduates. The total average (SD) pretest score was 6.7±1.6/10. The total average post-test score was 7.0±1.9/10. The total point increase from pre-test to post-test was 0.3 (p=0.002). Of the 556 SC AMEN Program participants, 77% completed a prostate cancer screening (n=217/39%) or have scheduled a screening appointment (n=209/38%). The remaining 23% continue to be navigated to a screening appointment. Conclusions: The SC AMEN Program was successful in increasing the participants’ knowledge of prostate cancer and their access to prostate cancer screening. Citation Format: Amber S. McCoy, Marvella E. Ford, Angela M. Malek, Melanie Slan, Claudia E. Lawton, Lee H. Moultrie, Kenneth Swaringer, I'Ayana Sanders, Adam Pressley, Ellen Gomez, Jessica zserai, Joan McLauren, pMina Platt, Phuong Le, Chloe Keeve, Joie Zabec, Marla Sagatelian, Benjamin Stone, Nicholas Shungu. The SC AMEN program: Testing a centralized patient navigation intervention for prostate cancer screening in Black men [abstract]. In: Proceedings of the 18th AACR Conference on the Science of Cancer Health Disparities; 2025 Sep 18-21; Baltimore, MD. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2025;34(9 Suppl):Abstract nr B083.

Cancer Epidemiology Biomarkers & PreventionVol. 34(9_Supplement)
South Carolina State University (US), Medical University of South Carolina (US), Charles River Associates (US)
Openalex Percentile: Top 65%
Global Cancer Incidence and Screening
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.